Targeted Oncology presents Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.
Expert Perspectives on the Treatment of Advanced Clear Cell Renal Cell CarcinomaMarch 29th 2023
A panel of expert genitourinary oncologists present the case of a patient with advanced clear cell renal cell carcinoma and have a comprehensive discussion on clinical trial data and treatment decisions.
Biomarker Testing in Non-Small Cell Lung CancerFebruary 21st 2023
Jason Porter, MD, Eric Vail, MD, and Ana Velázquez Mañana, MD, MSc, present two clinical cases of non-small cell lung cancer (NSCLC), discuss targetable genomic alterations and their approaches to biomarker testing for these patients, and touch on how socioeconomic and racial disparities may effect use of testing.
The Role of BCMA-Directed Therapy in Relapsed Refractory Multiple Myeloma (R/R MM)February 9th 2023
A panel of experts in multiple myeloma reviews key clinical trial data on the treatment of relapsed/refractory multiple myeloma (R/R MM) and discusses the best treatment approaches in the context of recent treatment approvals.
Advances in Targeted Therapies for Non-Small Cell Lung CancerNovember 10th 2022
In this panel discussion, experts review clinical cases of metastatic non-small cell lung cancer (mNSCLC), discuss commonly observed targetable genomic alterations, and share their perspectives on key clinical trial data that could impact treatment decision-making.
Advances in the Diagnosis and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)September 30th 2022
An expert panel including two hematologist-oncologists and a pathologist center discussion on patient cases to review the optimal identification and management of blastic plasmacytoid dendritic cell neoplasm.